CATEGORIES

Clinical Trials

LATEST

TRENDING

EDITORS CHOICE

Health Possibilities We Can’t Afford to Block

Fixing one piece of the healthcare puzzle is encouraging - but is it transformational? Here are 10 things we can consider to make things better.

Hepion Pharmaceuticals’ CRV431 Demonstrates Efficacy in Kidney Fibrosis

CRV431 has exerted antifibrotic activity in a number of in vitro and in vivo studies conducted by independent research laboratories

Colchicine Shows 48% Reduction in Future Cardio Issues for Heart Attack Victims

Early, in-hospital treatment with colchicine reduces the odds of future cardiovascular problems by 48% in people who have just survived a heart attack

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients